Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults.
Abstract
Multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS)
are plasma cell disorders of aging. The landscape of the diagnosis and management
of MM and MGUS are rapidly changing. This article provides an updated understanding
of the clinical presentation, evaluation, diagnosis, and management of older adults
with MM and MGUS. Because most oncology providers are not formally trained in geriatric
medicine, geriatricians play a key role in providing oncologists with a broader understanding
of patient health status in the hope of improving outcomes for older adults with MM.
Type
Journal articleSubject
CancerElderly
Geriatric
MGUS
Multiple myeloma
Neoplasm
Older adult
Aged
Aged, 80 and over
Comorbidity
Geriatric Assessment
Health Status Indicators
Humans
Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Risk Factors
Permalink
https://hdl.handle.net/10161/11590Published Version (Please cite this version)
10.1016/j.cger.2015.08.012Publication Info
Guerard, EJ; & Tuchman, SA (2016). Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older Adults.
Clin Geriatr Med, 32(1). pp. 191-205. 10.1016/j.cger.2015.08.012. Retrieved from https://hdl.handle.net/10161/11590.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Sascha Alexander Tuchman
Assistant Professor of Medicine
This author no longer has a Scholars@Duke profile, so the information shown here reflects
their Duke status at the time this item was deposited.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles